Press Releases

Investor E-mail Alert Service: You can automatically receive Press Release alerts via e-mail by subscribing now.

Keyword Search
 
07/12/2018
BD Shares Progress towards Achieving 2020 Sustainability Goals
07/09/2018
BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease
07/05/2018
BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call
06/04/2018
BD to Present at Investor Healthcare Conferences
06/04/2018
BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution
06/01/2018
BD Names John DeFord Chief Technology Officer
05/03/2018
BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance
04/27/2018
BD Names Three Executives to Segment Leadership Roles
04/26/2018
BD Launches BD FACSymphony™ S6 High Parameter Cell Sorter to Enable Sorting of Rare Cell Types
04/23/2018
BD Board Declares Dividends
04/19/2018
BD Unveils Suite of Diagnostic Informatics and Automation Innovations
04/03/2018
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
03/22/2018
BD Updates Instructions for Use for Certain BD Vacutainer® Blood Collection Tubes
03/19/2018
BD to Divest Remaining Investment in Vyaire Medical to Funds Managed by Apax Partners
03/08/2018
BD to Present at the Barclays Global Healthcare Conference
03/05/2018
BD to Demonstrate Enhanced Integration Offerings that Target Key Gaps Across the Medication Management Process at HIMSS18
03/01/2018
BD Announces Results of Offer to Repurchase its 3.000% Notes Due 2026
02/28/2018
BD to Present at the Raymond James 39th Annual Institutional Investors Conference
02/20/2018
BD Launches Circulating Cell-Free DNA Blood Collection Tube for Cancer and Non-Invasive Prenatal Testing Applications
02/15/2018
BD Completes Asset Divestitures to Merit Medical
02/13/2018
FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer
02/08/2018
BD to Present at Leerink Partners 7th Annual Global Healthcare Conference
02/06/2018
BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard
02/02/2018
Comparable Historical Revenue Schedules Inclusive of C. R. Bard Posted to BD Website
02/01/2018
BD Launches New Los Angeles County Program to Equip Patients with Essential Resources for Safe Sharps Disposal
01/22/2018
BD Board Declares Dividend
01/18/2018
BD Announces Completion of Enrollment in the Lutonix™ 014 Drug Coated Balloon Below-The-Knee Trial
01/17/2018
BD Announces Webcast of Annual Meeting of Shareholders
01/15/2018
BD and Check-Points Receive CE Mark for Next-generation Resistant Bacteria Screening Test
01/12/2018
BD Statement on FDA Warning Letter for Preanalytical Systems Business Unit
01/11/2018
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
01/08/2018
BD Announces Commencement of Offer to Repurchase its 3.000% Notes Due 2026
01/03/2018
BD to Present at the 36th Annual J. P. Morgan Healthcare Conference